The company announced on Tuesday
PHOTO
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
The U.S. Food and Drug Administration (FDA) has declined to approve ARS Pharmaceuticals' nasal spray for allergic reactions, the company said on Tuesday. (Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Maju Samuel and Dhanya Ann Thoppil)
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
